The Pharmaceuticals in Dosage Market in Vietnam has shown a growth trajectory over the last decade, rising from $41.59 per capita in 2012 to $59.05 in 2022. Notable year-on-year variations have been observed, especially a significant increase in 2021 (13.13%) followed by a modest decline in 2022 (-6.97%). The five-year compound annual growth rate (CAGR) from 2017 to 2022 stands at around 1.21%, indicating a steady yet fluctuating market expansion.
Looking forward, industry stakeholders should monitor key trends such as the impact of healthcare policy reforms, the introduction of new pharmaceutical products, and economic shifts that could influence consumer spending on medications. Additionally, the increasing penetration of digital health solutions may transform the landscape, driving further growth and accessibility in the pharmaceuticals market in Vietnam.
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 45 | 45 Bolivia | 64.37 | 2023 | View data | ||
| 46 | 46 Senegal | 61.39 | 2023 | View data | ||
| 47 | 47 Vietnam | 60.03 | 2023 | |||
| 48 | 48 Thailand | 56.22 | 2023 | View data | ||
| 49 | 49 Tunisia | 50.43 | 2023 | View data | ||
